Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Marila Gennaro
Rbhs New Jersey Medical School, Department: Public Health & Prev Medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Rutgers University
Other : Rutgers University held IP
Existing immunological tests for tuberculosis (TB) are inadequate for diagnosis and for prognosis. They are unable to identify reactivation of latent TB disease or preclinical TB disease. These tests rely on measurement of response from a large number of various T cells (immune cells). The investigators hypothesize that using single cell assays of T cell activation will provide sufficiently fine-grained analysis to overcome the limitations of TB skin tests and blood-based interferon gamma release assays (IGRAs). Dr. Gennaro has previously developed a cell based assay to detect TB (PHRI Case 105 — "Rapid Assays for T-Cell Activation by RNA Measurement Using Flow Cytometry”; Rutgers Tech ID: S 12-006)) that provides royalties through the Rutgers University Office of Commercialization. Since this patent is related to the current work, the RU COI Committee has found this interest to be in conflict with the funded study.
FISH-Flow platform for host-based tuberculosis diagnostics
Fast, affordable and reliable diagnosis of an infection with the bacteria that cause tuberculosis before a person shows symptoms is critical to eliminating tuberculosis. This collaborative proposal establishes a partnership toward development of a next-generation diagnostic test for tuberculosis between academic investigators and a medical diagnostics company that has already developed FDA-approved tuberculosis diagnostics. The plan is designed to refine and validate a promising diagnostic procedure (assay) that detects the responses of human immune cells to tuberculosis infection, resulting in both manual and semi-automated versions of the assay that will determine whether a person is infected with the bacteria and the stage of that infection.
Filed on July 12, 2016.
Tell us what you know about Marila Gennaro's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Marila Gennaro”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Marila Gennaro | Rbhs New Jersey Medical School | Conflict of Interest | Rutgers University | $300,000 - $349,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.